Clinical trials
Phase 3 Virus Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
89 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 6 |
| 2011 | 6 |
| 2012 | 8 |
| 2013 | 8 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 11 |
| 2021 | 9 |
| 2022 | 2 |
| 2023 | 6 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 75 |
| Recruiting | 5 |
| Unknown status | 4 |
| Terminated | 2 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ModernaTX, Inc. | 11 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 10 |
| Crucell Holland BV | 8 |
| Gilead Sciences | 8 |
| National Center for Research Resources (NCRR) | 6 |
| MCM Vaccines B.V. | 4 |
| GlaxoSmithKline | 3 |
| Medicago | 3 |
| Valenta Pharm JSC | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Virus Diseases | 89 |
| RNA Virus Infections | 27 |
| Coronavirus Infections | 24 |
| COVID-19 | 22 |
| Influenza, Human | 20 |
| Coronaviridae Infections | 16 |
| Nidovirales Infections | 14 |
| Severe Acute Respiratory Syndrome | 14 |
| Respiratory Tract Infections | 13 |
| Hepatitis C | 11 |
Trials
Showing 1 to 25 of 89. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.